Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for phantom limb pain after leg amputation
ACTRN12608000088347Phase 4Not yet recruiting
- Sponsor
- Hunter Integrated Pain Service
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in phantom limb pain (PLP) comparing Pregabalin with Placebo (2 arms). Primary endpoint: Reduction in incidence of phantom pain. Planned start Mar 2008; status: not yet recruiting.
02
Drugs
pregabalin
03
Conditions
phantom limb pain (PLP)
Beyond the preview
Go deeper on ACTRN12608000088347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000088347.